Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03110692 · ClinicalTrials.gov registry record · NA
Default Options to Reduce Unnecessary Daily Imaging During Palliative Radiation
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 1,188
- Enrollment target
NCT03110692: Completed NA study, sponsored by University of Pennsylvania.
NCT03110692 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 1,188 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03110692, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,188 participants
- Enrollment target
Study Summary
The goal of this study is to reduce preference sensitive, unnecessary daily imaging during radiation treatment in which a pre-planned quality improvement default option for radiation treatment prescriptions will be introduced throughout the network of Penn Radiation Oncology.
Interventions
- BEHAVIORAL Default initiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,188 participants |
| Start Date | 2016-02-10 |
| Est. Completion | 2018-02-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03110692
The ClinicalTrials.gov registry entry for NCT03110692 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,188 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Default initiation is the first listed.
NCT03110692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03110692 about?
NCT03110692 is a clinical study titled "Default Options to Reduce Unnecessary Daily Imaging During Palliative Radiation". The goal of this study is to reduce preference sensitive, unnecessary daily imaging during radiation treatment in which a pre-planned quality improvement default option for radiation treatment prescriptions will be introduced throughout the network of Penn Radiation Oncology.
What is the current status of trial NCT03110692?
This trial is currently completed. It is a NA study. The enrollment target is 1,188 participants. The study started on 2016-02-10. Estimated completion is 2018-02-09.
What interventions are being tested in trial NCT03110692?
The interventions under investigation include: Default initiation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03110692?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.